Pharmacy Podcast Network

The Pharmacy 50 Awards are back for the 2025 season, celebrating the people who are pushing the profession forward through leadership, innovation, advocacy, education, and patient care. In Part 2 of this 4-part series, we spotlight an incredible group of pharmacy professionals and industry leaders representing the full spectrum of pharmacy—from independent practice and health systems to digital health, specialty pharmacy, philanthropy, and beyond. This series is designed to recognize the voices shaping the future of pharmacy and to inspire the next wave of leadership across healthcare.   Walter Oronsaye PharmD — Social Media Influencer Emily Durham, MS, CPhT — Compounding Christopher Bowens, PharmD — Health System Hospital Pharmacy Mark Duman, MRPharmS — Technology & Digital Health Greg Reybold — Advocacy, Policy, Regulation or Government Dave Randolph, BSPharm — Independent Pharmacy Kelley D. Carlstrom, PharmD — Specialty Pharmacy Andy Crawford — Independent Pharmacy Brandi Chane, CPhT — Independent Pharmacy Mayank Amin, PharmD — Independent Pharmacy Chris Antypas, PharmD — Specialty Pharmacy Tarah Slusher Davis, PharmD — Independent Pharmacy

TWIRx – January 30 | Special Guest: Marc Essensa, CEO of IPC On this episode of This Week in Pharmacy, we welcome Marc Essensa, President and CEO of the Independent Pharmacy Cooperative (IPC), to discuss timely strategies and resources helping independent pharmacies strengthen their businesses in today’s challenging environment. Building Your Independent Pharmacy Business Marc shares insights on navigating reimbursement pressure, improving margins, and leveraging IPC’s purchasing power, data, and strategic tools to support long-term sustainability. The Payment Card Settlement: A Practical Guide We break down IPC’s guidance on the Payment Card Interchange Fee Settlement, which may allow pharmacies that accepted Visa or Mastercard between 2004–2019 to recover funds. Marc explains eligibility, next steps, and how recovered dollars can support cash flow, staffing, technology, or inventory investments. IPC Member Support Services The conversation highlights IPC’s expanded member support offerings, including business consulting, strategic partnerships, wholesale access, and operational resources designed to help independents stay competitive. Legislative & Advocacy Updates Marc also provides updates on IPC’s advocacy efforts at both the state and federal levels, focused on protecting independent pharmacy interests and addressing ongoing policy and reimbursement challenges. 🔗 Resource Mentioned The Payment Card Settlement: A Practical Guide – IPC https://www.ipcrx.com/pharmacy-blog/news/the-payment-card-settlement-a-practical-guide/ Special guest:  Sakhi Gaurang Patel is a trailblazing PharmD candidate at the UC Irvine School of Pharmacy & Pharmaceutical Sciences and a co-founder of the startup CuraVoice. Recognized for her work in healthcare equity, mentorship, and educational technology, she focuses on improving patient communication and reducing health disparities. Featured Guest: Dr. Jenny Newlon, PharmD — Researcher and Pharmacist with Birth Control Pharmacist In this episode of This Week in Pharmacy, we sit down with Dr. Jenny Newlon to explore how pharmacist consultants, health clinics, and independent pharmacies can build high-value contraception services that meet urgent community needs. We discuss practical strategies for delivering accessible birth control care—especially in areas that have lost Planned Parenthood centers—while creating new revenue models outside the constraints of traditional PBM reimbursement. Dr. Newlon breaks down: How pharmacies can implement contraception services—even with limited staff or clinical infrastructure Ways to deliver value to patients and communities through education, access, and continuity of care Forward-thinking business models that diversify revenue beyond dispensing Tune in to learn how independent pharmacy teams can lead with care, expand women’s health access, and strengthen their role as trusted healthcare providers. Today's "This Week in Pharmacy" is sponsored by Independent Pharmacy Cooperative (IPC)

In this powerful episode of MaternalRx on the Pharmacy Podcast Network, host Danielle Plummer, PharmD, speaks with pharmacist Willie Bawarski and his wife, Olivia, about their deeply personal journey through infertility, IVF treatment, foster care, and adoption. Willie and Olivia share the emotional, physical, and financial realities of trying to conceive, navigating fertility treatments, and facing the grief that often accompanies infertility. When their path to parenthood changed, they chose to open their hearts and home through foster care and adoption, ultimately building a beautiful family in ways they never expected. This conversation highlights the critical role pharmacists and healthcare professionals play in supporting patients experiencing infertility and those considering foster care or adoption. Listeners will gain practical insight into using compassionate language, empathy, and trauma-informed care to support individuals and couples during some of the most vulnerable seasons of their lives. Whether you are facing infertility, exploring IVF, considering adoption, working within maternal health, or caring for patients on these journeys, this episode offers hope, validation, and a reminder that family is defined by love, not biology. 🔗 Learn more about adoption: https://adoptuskids.org/ 🔗 Connect with Danielle Plummer, PharmD: www.linkedin.com/in/daniellerplummer/

There is still a lot more you should know about drastic price reductions on key brand name drugs.   The Manufacturer Fair Price (MFP) price reductions have now hit, but there are still things a pharmacy can do to mitigate gross profit loses.  Jay Blackburn, CEO of the Compliant Pharmacy Alliance (CPA) shares several tips, tactics and techniques that he suggests you understand.  It will pay for you to understand and act on now! More information can be had on the CPA website:  www.compliantrx.com 

What happens when your doctor prescribes a medication that does not exist? Not backordered. Not insurance denied. It simply is not made anywhere. In this episode of Rated Rx Podcast, pharmacists break down compounding pharmacy, why it exists, and why some patients would not survive without it. This is one of the most misunderstood areas of healthcare, and it answers a question people search online every day: what happens when standard medications do not work for you? You hear real examples involving pediatric epilepsy, elderly patients with complex medication regimens, feeding tubes, allergies to dyes and fillers, and rare conditions where mass-produced drugs fail. The episode explains how compounding pharmacists legally create customized medications by changing dosage forms, removing allergens, combining medications, and creating formulations that pharmaceutical companies never made. The crew also tackles the biggest misconception around compounding medications, including why compounded drugs are not FDA approved, what regulations actually apply, how USP standards protect patients, and why this work is highly regulated rather than experimental. Sterile compounding, non-sterile compounding, safety checks, pharmacist verification, and real-world problem solving are all explained clearly so you understand how these medications are made safely and legally. This episode helps patients, caregivers, and healthcare professionals understand when compounding is appropriate and why asking about it can change outcomes. For educational and entertainment purposes only. Follow Us At: YouTube https://www.youtube.com/@RatedRxPodcast Instagram https://www.instagram.com/ratedrxpodcast/ Facebook https://www.facebook.com/profile.php?id=61574813907982 TikTok https://www.tiktok.com/@ratedrxpodcast

The Pharmacy 50 Awards are back for the 2025 season, celebrating the people who are pushing the profession forward through leadership, innovation, advocacy, education, and patient care. In Part 1 of this 4-part series, we spotlight an incredible group of pharmacy professionals and industry leaders representing the full spectrum of pharmacy! From independent practice and health systems to digital health, specialty pharmacy, philanthropy, and beyond. This series is designed to recognize the voices shaping the future of pharmacy and to inspire the next wave of leadership across healthcare. 🎙️ Featured Honorees Part One Technology & Digital Health Yalda Olcott, PharmD — Technology & Digital Health Autumn-Kyoko Cushman — Technology & Digital Health Independent Pharmacy Josh Pirestani — Independent Pharmacy Amina Abubakar, PharmD — Independent Pharmacy Shawn Nairn, RPh — Independent Pharmacy Health System / Hospital Pharmacy Ultan McGlone, PharmD — Health System Hospital Pharmacy Alex C. Varkey, PharmD — Health System Hospital Pharmacy Brianna Latta, PharmD — Health System Hospital Pharmacy Academia & Pharmacy Education C. Daniel Mullins, PhD — Academia & Pharmacy Educator Philanthropy | Charitable Pharmacy Jordyn Nordé, PharmD — Philanthropy | Charitable Pharmacy Specialty Pharmacy Laly Havern, PharmD — Specialty Pharmacy Pharmacy Technician Ellaine Sisomphou-Ramos, CPhT — Pharmacy Technician Medical Affairs / Industry Brandon Shank, PharmD — Medical Science Liaison Social Media Influence Laura Dowling, BPharm — Social Media Influencer ⭐ What You’ll Hear in This Episode In this first installment, we highlight how today’s pharmacy leaders are: Advancing innovation and digital transformation Strengthening independent pharmacy impact in local communities Elevating health system pharmacy practice and patient safety Expanding pharmacy’s influence through education, research, and advocacy Supporting access to care through charitable pharmacy and philanthropy Growing specialty pharmacy leadership and patient outcomes Recognizing the essential role of pharmacy technicians Driving clinical education and strategy in medical affairs Using platforms and storytelling to shape pharmacy’s public voice 📌 About the Pharmacy 50 Awards The Pharmacy 50 Awards recognize individuals across pharmacy and healthcare who are creating measurable impact, leading change, and building the future of the profession. The 2025 season showcases innovators, disruptors, and patient-centered leaders who represent pharmacy’s growing role in healthcare delivery.

In this episode of This Week in Pharmacy, we explore how the Pharmacy Podcast Network (PPN) is deepening connections across healthcare by elevating pharmacists’ voices in the conversations that matter most. Inspired by the recent partnership between podcasting giant PodcastOne and the AI-driven analytics platform Listener, we highlight how PPN is using the same type of advanced engagement metrics—combining podcast listener data, social media signals, and network insights—to measure true influence, not just downloads.  With Listener’s powerful data, PPN can now identify where pharmacists are making the greatest impact and uncover new opportunities to expand pharmacist positioning with other providers, industry leaders, and the public. Plus, Todd sits down one-on-one with Kris Rhea of Pharmacy Market Place for an insightful conversation on AI in pharmacy—exploring how artificial intelligence is shaping workflow, clinical decision-making, business operations, and what pharmacists need to know to stay ahead in a rapidly changing healthcare landscape.

In Episode 3 of Pharmacist-Prescribed, hosts Mary Kucek, PMP, Founder and CEO of OvaryIt, and Devin Bustin, MD, Chief Medical Officer of OvaryIt, explore how pharmacies can turn clinical services into sustainable, profitable offerings. The episode breaks down patient acquisition strategies, common billing and reimbursement challenges, staffing considerations, and how pharmacies can integrate clinical care without increasing overhead. Listeners will also learn how technology and policy changes, including the ECAPS Act, play a critical role in positioning pharmacists for long-term success as providers. Learn more about PRISM or request a demo at https://www.getprismrx.com

Cyber threats facing long-term care pharmacies continue to evolve, putting sensitive data, systems, and patient trust at risk. In this episode of FrameworkFocus, host Todd Eury sits down with Scott Beatty, President & CEO of SoftWriters, and Chris Callahan of Echelon Risk + Cyber to explore today’s threat landscape and practical strategies to strengthen cybersecurity maturity. From leadership accountability to real-world defense tactics, discover how pharmacies can improve security hygiene and build resilience without slowing innovation.

The American Diabetes Association's 2026 Standards of Care in Diabetes are here! Let’s talk about what’s changed and how to better care for our older adults living with diabetes. 2026 Standards of Care in Diabetes:  https://diabetesjournals.org/care/issue/49/Supplement_1 Tamara Ruggles, PharmD, BCGP, FASCP:  www.linkedin.com/in/tamara-ruggles-491882251 Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES:  https://www.linkedin.com/in/diana-isaacs-pharmd-bcps-bcacp-bc-adm-cdces-45803426/

I was blown away by today’s guest in his ability to educate on complex mechanisms of actions, as well as his innovation and humility. We touched on so many topics that I had to split this episode in two parts! It was truly reassuring and empowering to learn about healing with natural, science-backed tools to reduce inflammation, the hidden root cause of aging, chronic disease, and cancer.  In these two episodes, you will learn how inflammation impacts health at a cellular level and how you can take proactive steps to restore vitality, strengthen immunity, and age with resilience.  Samuel Shepherd is an award winning physicist, inventor, and engineer with 42 patents and over 50 years of breakthroughs across biochemical, environmental, and medical engineering. His career has taken him from developing technologies for NASA and the Beijing Olympics to pioneering solutions in alternative energy and environmental remediation. But it was a deeply personal health challenge that led him to his most life-changing discovery.  In 2003, Samuel was diagnosed with a rare, untreatable bone marrow cancer. Conventional medicine offered no viable path forward, so he turned to his lifelong expertise in science and innovation. After years of research, he developed ValAsta, the only patented glycosidic form of astaxanthin designed specifically to target inflammation, the root cause of most chronic disease. His unique delivery system makes astaxanthin far more bioavailable than typical supplements, producing remarkable results for energy, mobility, sleep, and overall vitality in both people and pets. Today, Samuel is on a mission to educate others about how inflammation accelerates disease and diminishes quality of life, and how targeted natural solutions can restore health. Beyond his formidable credentials, his personal story of overcoming terminal illness fuels his passion for helping others age with strength, energy, and resilience. Connect with Samuel via: Email: info@valasta.net  Website: ValAsta  FB: ValAsta Youtube: @ValAsta Visit https://marinabuksov.com for more holistic content. Music from https://www.purple-planet.com.  Disclaimer: Statements herein have not been evaluated by the Food and Drug Administration. Products listed are not intended to diagnose, treat, cure, or prevent any diseases.

On today’s Executive Dose, host Stephen Beckman is joined by Representative Charity Grimm Krupa, who serves Pennsylvania’s 51st District in the House of Representatives, for a timely and insightful discussion on the evolving healthcare policy landscape in the Commonwealth. Together, they explore recent legislative developments in Pennsylvania that are shaping healthcare delivery, access, and affordability, with a particular focus on how state-level decisions often serve as early indicators for broader national trends. Stephen and Representative Grimm Krupa also examine the ripple effects Pennsylvania healthcare policy can have beyond state borders, highlighting why pharmacists, healthcare leaders, and industry stakeholders across the country should be paying close attention. From regulatory considerations to workforce challenges and patient-centered care initiatives, this episode offers valuable perspective on the intersection of policy, leadership, and healthcare innovation—and what it could mean for the future of healthcare nationwide.

I was blown away by today’s guest in his ability to educate on complex mechanisms of actions, as well as his innovation and humility. We touched on so many topics that I had to split this episode in two parts! It was truly reassuring and empowering to learn about healing with natural, science-backed tools to reduce inflammation, the hidden root cause of aging, chronic disease, and cancer.  In these two episodes, you will learn how inflammation impacts health at a cellular level and how you can take proactive steps to restore vitality, strengthen immunity, and age with resilience.  Samuel Shepherd is an award winning physicist, inventor, and engineer with 42 patents and over 50 years of breakthroughs across biochemical, environmental, and medical engineering. His career has taken him from developing technologies for NASA and the Beijing Olympics to pioneering solutions in alternative energy and environmental remediation. But it was a deeply personal health challenge that led him to his most life-changing discovery.  In 2003, Samuel was diagnosed with a rare, untreatable bone marrow cancer. Conventional medicine offered no viable path forward, so he turned to his lifelong expertise in science and innovation. After years of research, he developed ValAsta, the only patented glycosidic form of astaxanthin designed specifically to target inflammation, the root cause of most chronic disease. His unique delivery system makes astaxanthin far more bioavailable than typical supplements, producing remarkable results for energy, mobility, sleep, and overall vitality in both people and pets. Today, Samuel is on a mission to educate others about how inflammation accelerates disease and diminishes quality of life, and how targeted natural solutions can restore health. Beyond his formidable credentials, his personal story of overcoming terminal illness fuels his passion for helping others age with strength, energy, and resilience. Connect with Samuel via: Email: info@valasta.net  Website: ValAsta  FB: ValAsta Youtube: @ValAsta Visit https://marinabuksov.com for more holistic content. Music from https://www.purple-planet.com.  Disclaimer: Statements herein have not been evaluated by the Food and Drug Administration. Products listed are not intended to diagnose, treat, cure, or prevent any diseases.

Opioidology Part 3: Opioid-Philia vs Opioid-Phobia The often-blurred lines of pain, addiction, and substance use need a deeper dive into the extremes of opioid-philia and opioid-phobia (building upon Opioidology Part 1: Our Opioid Story). Join Mark “Pain Guy” Garofoli and our two guests James Hackworth and Jim Potenziano to take that deeper dive based on their recent collaboration in the Frontiers in Pain Research article “The Burden of Acute Pain in the U.S. in the Wake of the Opioid Crisis”. • Frontiers in Pain Research Article: https://www.frontiersin.org/journals/pain-research/articles/10.3389/fpain.2025.1642035/full  • Article Key Takeaways • Rising Pain Prevalence • Balancing Act—Opioid Utilization vs. Undertreatment • Provider Reluctance to use opioids • Patient Reluctance • Massive Economic Impact • Call for Innovation & Policy Reform • Opioid Story charts: www.painguy.us

In this episode of the Rated Rx Podcast, pharmacists break down the biggest healthcare news of 2025 and what it actually means for patients and clinicians 👀💊. You hear real pharmacist perspectives on artificial intelligence in healthcare, new federal plans to regulate AI, and why clinical judgment, patient trust, and human decision making still matter more than algorithms 🤖➡️🧠. The conversation also dives into major vaccine policy changes, including updates to newborn hepatitis B vaccination recommendations and why shifts like this raise real concerns for public health 🧬🩺. The crew explains what these changes mean in practice, how misinformation spreads fast, and why prevention still saves lives. Later, the episode tackles the explosion of GLP 1 weight loss medications like semaglutide and tirzepatide. You hear honest discussion about access, cost, compounding risks, and why obesity needs to be treated as a chronic disease instead of a personal failure ⚖️📈. This episode blends news, clinical insight, and real world experience to unpack where healthcare is heading next. This podcast is intended for entertainment and informational purposes only. Listen and Follow Rated Rx 🎙️ Apple Podcasts https://podcasts.apple.com/us/podcast/the-rated-rx-podcast/id1804181016 Spotify https://open.spotify.com/show/7KATtG1c3HwwYpVMtRuNub Facebook https://www.facebook.com/profile.php?id=61574813907982 Instagram https://www.instagram.com/ratedrxpodcast/ TikTok https://www.tiktok.com/@ratedrxpodcast

In this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Simone Colgan Dunlap, National Vice Chair of the Quarles Health and Life Sciences Practice Group, and Amy Cotton Peterson, Partner at Quarles. As more automation solutions become available, its vital specialty pharmacy providers strategically approach acquisition of targets that offer technology and AI assets. This discussion explores effective diligence practices, common pitfalls, and risk mitigation strategies for specialty pharmacies navigating mergers and acquisitions and the rapidly evolving use of artificial intelligence.

🎙️ This Week in Pharmacy (TWIRx) — January 9, 2026 Welcome to TWIRx — This Week in Pharmacy! I’m your host Todd Eury, and today’s episode is sponsored by YARAL Pharma, a generics company committed to “Doing Things Differently”—with a human-centered, untraditional approach that’s redefining relationships between industry and pharmacy practice.  ✅ Today’s Sponsor: YARAL Pharma YARAL Pharma is committed to innovation, partnership, and supporting pharmacists at the front lines—especially as healthcare continues to restructure and the role of the pharmacist becomes more essential than ever. Their mission to Do Things Differently is more than a slogan—it’s a commitment to reshaping what a generics company can stand for in today’s healthcare marketplace.  📰 This Week in Pharmacy — News 1) Amazon Pharmacy to Offer Novo Nordisk’s Wegovy Pill Nationwide Amazon Pharmacy is now offering Novo Nordisk’s newly FDA-approved Wegovy pill, making the weight-loss medication available nationwide through both insurance coverage and cash-pay options. This move continues Amazon’s expansion into digital healthcare access—bringing blockbuster GLP-1 therapies directly to consumers and increasing competition among major pharmacy providers. https://www.mobihealthnews.com/news/amazon-pharmacy-offer-novo-nordisks-wegovy-pill 2) Dr. David Pope: AI, Online Pharmacies, and Why the Neighborhood Pharmacist Still Wins Trust In a must-read guest column, Dr. David Pope argues that while AI and online pharmacy services are rapidly surging, the community pharmacist remains one of the most trusted healthcare professionals in America. He points to how pharmacy deserts, increasing reimbursement pressure, and policy reform will reshape pharmacy in 2026—and why the profession’s future will depend on protecting and empowering local pharmacy care. https://drugstorenews.com/ai-and-online-pharmacy-surge-neighborhood-pharmacist-remains-most-trusted  3) Pharmacist Leadership Spotlight: Illuminate Rx Names Ritu Malhotra, PharmD, as President Illuminate Rx announced the appointment of Ritu Malhotra, PharmD, as its new President, reinforcing the growing trend of pharmacists stepping into leadership roles across pharmacy benefits and PBM reform. With decades of experience modernizing healthcare and pharmacy benefit strategy, Malhotra’s appointment signals Illuminate Rx’s focus on improving transparency and clarity in pharmacy benefits management. https://www.prnewswire.com/news-releases/illuminate-rx-appoints-industry-veteran-ritu-malhotra-pharmd-as-president-to-advance-clarity-in-pharmacy-benefits-302657441.html 4) Viatris Exec David Marin Named New CEO of PCMA The Pharmaceutical Care Management Association (PCMA)—the leading PBM trade group—has named David Marin, previously Head of Global Government Affairs & Public Policy at Viatris, as its next President and CEO effective January 30, 2026. His selection comes at a pivotal time as PBMs face rising scrutiny and intensifying policy pressure nationwide. https://www.healthcaredive.com/news/pcma-names-new-ceo-david-marin/809158/  🎤 Interviews & Segments ⭐ Segment 1 — Special Sponsor Interview Stephen Beckman, CEO of YARAL Pharma We kick off TWIRx with a special conversation featuring Stephen Beckman, CEO of YARAL Pharma, exploring what 2026 has in store for pharmacy and healthcare. We discuss the Pharmacy 50 Awards, the importance of honoring leadership across the profession, and why supporting pharmacists right now—during one of the most fragile and transformative moments in U.S. healthcare—is absolutely critical. ⭐ Featured Interview — Pennsylvania State Representative Rep. Charity Grimm Krupa — 51st Legislative District Today’s featured interview is with State Representative Charity Grimm Krupa, who represents Pennsylvania’s 51st Legislative District in the House of Representatives. We discuss real healthcare issues impacting Pennsylvanians—including medical cannabis, small business healthcare benefit strategies, and why it’s essential for healthcare professionals to stay connected with their state lawmakers. Rep. Krupa also shares why every citizen should aim to communicate with their own representatives at least once per year. ⭐ Segment 2 — Clinical & Policy Spotlight Dr. Sally Rafie, PharmD — “The Birth Control Pharmacist” In our second segment, we welcome Dr. Sally Rafie, PharmD, nationally known as the “Birth Control Pharmacist.” Dr. Rafie is a clinical pharmacist specialist at UC San Diego Health and an assistant clinical professor at the UC San Diego Skaggs School of Pharmacy, widely recognized for advancing pharmacists’ role in reproductive health care. She is also the founder of Birth Control Pharmacist, an education and training company that equips pharmacists and healthcare teams to prescribe and deliver contraception care through evidence-based resources, clinical updates, and advocacy support—helping expand access to contraception through pharmacies nationwide. 🔔 Closing That wraps up this week’s episode of This Week in Pharmacy. Thanks for tuning in—and thank you again to YARAL Pharma for sponsoring today’s TWIRx. If you enjoyed today’s episode, please share it with a fellow pharmacist, leave a review, and stay connected as we continue to cover the stories shaping the pharmacy profession. See you next week on TWIRx when we celebrate the "50 Most Influential People in Pharmacy" Awards LIVE!!

In this edition of Essential, we’ve got concerns about the FDA’s revolving door, some issues with a new California law that might affects the whole country, and a new accreditation that might save a lot of headache. Then we take a deep dive into the once and future world of compounded peptides — where they are, and where they might be going … and why. Links FDA’s revolving door: https://archive.ph/oxBXP  Join APC today: https://a4pc.org/membership  Coalition for Compounding Excellence (CCE) accreditation: https://414uue.share-na2.hsforms.com/2n_hRAnRSQ4O8VteGTesF0Q?_hsenc=p2ANqtz-9rfyq3GuFFZw6omRa96tq_es549FWmjiw-sP5NU3LKrsL1eump-l18h7xVrvy8G_V1Pi4UFkfhARMnPCLIx7TBOwPClQ&_hsmi=394109070 Pharma Source Direct: https://www.linkedin.com/company/pharma-source-direct/

In Episode 2 of Pharmacist-Prescribed, hosts Mary Kucek, PMP, Founder and CEO of OvaryIt, and Devin Bustin, MD, Chief Medical Officer of OvaryIt, dive into the practical realities of implementing pharmacist-led prescribing services in community pharmacy settings. The conversation explores how pharmacies can navigate state-specific prescribing authority, standing orders, collaborative practice agreements, staffing concerns, and day-to-day workflows without disrupting existing operations. Listeners will gain a clear picture of how the PRISM platform supports safe, compliant, and efficient clinical service delivery, from patient intake and documentation to e-prescribing and team-based care. Learn more about PRISM or request a demo at https://www.getprismrx.com

I was truly inspired by today’s guest and her courage to follow her inner guidance, which served her not only on her personal journey but also led her to found a beautiful company with a sacred mission. Osi Mizrahi is the founder and visionary behind OSI Oils—a wellness brand rooted in slow beauty, Ayurvedic ritual, and the art of coming home to oneself. Born on a farm in Israel, Osi’s connection to the natural world began early, shaping her journey as a medical intuitive, Ayurvedic artisan, and guide in the healing arts. With over 30 years of experience in yoga, Ayurveda, Reiki, Kundalini, and Theta Healing, Osi blends ancient wisdom with feminine embodiment. Her work is inspired by Kabbalah, breathwork, and intuitive practices that support deep transformation. Osi believes in slow beauty and slow aging—practices that honor the body’s rhythms and nourish vitality over time. Oils, for her, are more than skincare—they are vessels of self-love, sensuality, and spiritual healing. Each OSI Oils formula is handcrafted in small batches using traditional Ayurvedic methods, turning everyday routines into sacred rituals. Whether soothing the nervous system with her belly oil or igniting life-force energy with Radiance Hair Oil, her products are designed to restore from the inside out. Osi’s upcoming book shares her own journey through heartbreak, healing, and the power of ancient rituals. Through her storytelling, mentorship, and botanical creations, she helps women around the world reconnect to their spark—and live with more pleasure, purpose, and presence. Connect with Osi via: Email: osi@osioils.com Website: Osi Oils IG: @osioils YT: @OsiMizrahi Linked In: Osi Mizrahi Use My Special Promo Code RAWFORK20 for 20% off orders on osioils.com Visit https://marinabuksov.com for more holistic content. Music from https://www.purple-planet.com. Disclaimer: Statements herein have not been evaluated by the Food and Drug Administration. Products listed are not intended to diagnose, treat, cure, or prevent any diseases.